Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Array Biopharma Inc patents

Recent patent applications related to Array Biopharma Inc. Array Biopharma Inc is listed as an Agent/Assignee. Note: Array Biopharma Inc may have other listings under different names/spellings. We're not affiliated with Array Biopharma Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Array Biopharma Inc-related inventors




Date Array Biopharma Inc patents (updated weekly) - BOOKMARK this page
09/14/17Quinazoline analogs as receptor tyrosine kinase inhibitors
09/14/172-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
09/14/17Point mutations in trk inhibitor-resistant cancer and methods relating to the same
09/07/17N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
08/31/17Process for making hydroxylated cyclopentylpyrimidine compounds
08/17/17Preparation of and formulation comprising a mek inhibitor
08/03/17Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
07/20/17Pharmaceutical formulations
06/22/17Method of treatment using inhibitors of mitosis
06/15/17Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
05/18/17Solid dispersions of a erb2 (her2) inhibitor
05/04/17Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
04/27/17Macrocyclic compounds as trk kinase inhibitors
04/27/17Method of treatment using substituted imidazo[1,2b]pyridazine compounds
04/27/17Macrocyclic compounds as trk kinase inhibitors
04/27/17Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
04/27/17Method of treatment using substituted imidazo[1,2b]pyridazine compounds
04/27/17Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
04/20/17Macrocyclic compounds as trk kinase inhibitors
04/06/17Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
03/30/171-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
03/09/17Mitotic kinesin inhibitors and methods of use thereof
03/02/17Pharmaceutical composition
12/29/16Combination of checkpoint kinase i inhibitors and wee i kinase inhibitors
12/22/16Pyrrolopyridines as kinase inhibitors
12/08/16Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
12/08/16Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
11/03/16Process for making hydroxylated cyclopentylpyrimidine compounds
10/20/16Serine/threonine kinase inhibitors
10/20/16Serine/threonine kinase inhibitors
10/13/16Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
10/13/16Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/29/16N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/29/16N-pyrrolidinyl,n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/29/16Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/29/16N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/29/16Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/22/16N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
09/01/16Crystalline forms of a pyrrolopyridine compound
09/01/16Method of treatment using substituted imidazo[1,2b]pyridazine compounds
08/18/16Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/11/16Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
07/14/16Process for preparing a compound
06/23/16Polymorphs of arry-380, a selective her 2 inhibitor and pharmaceutical compositions containing them
06/16/16Preparation of and formulation comprising a mek inhibitor
06/16/16Preparation of and formulation comprising a mek inhibitor
06/16/16Preparation of and formulation comprising a mek inhibitor
06/02/16Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Akt protein kinase inhibitors
05/19/16Substituted benzoazepines as toll-like receptor modulators
05/19/16Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
05/12/16Substituted benzoazepines as toll-like receptor modulators
05/05/16Serine/threonine kinase inhibitors
02/04/16Pharmaceutical composition 271
01/28/16Novel hydrogen sulfate salt
01/07/16Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof
01/07/16Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors
11/26/15Macrocyclic compounds as trk kinase inhibitors
11/12/15Pyrrolopyridines as kinase inhibitors
10/22/15Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol
10/22/15Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol
09/24/155h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
08/20/15Arry-520 for use in treating cancer in a patient with low aag
Patent Packs
08/20/156-substituted phenoxychroman carboxylic acid derivatives
07/30/15Mitotic kinesin inhibitors and methods of use thereof
07/16/15Pyrimidyl cyclopentanes as akt protein kinase inhibitors
07/09/15Dihydrofuro pyrimidines as akt protein kinase inhibitors
07/09/15Mitotic kinesin inhibtors and methods of use thereof
06/04/15Process for making hydroxylated cyclopentylpyrimidine compounds
05/14/15Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
04/23/15Treatment of brain cancer
04/09/15Process for making hydroxylated cyclopentylpyrimidine compounds
03/26/15Quinazoline compounds as serine/threonine kinase inhibitors
02/26/15Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives
02/19/15Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
02/12/15Filanesib combined with pomalidomide displays enhanced anti-tumor activity
01/29/15Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-indazol-5-yloxy)benzyl)urea hydrochloride
01/29/15Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors
Patent Packs
01/01/15Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
09/04/14Serine/threonine kinase inhibitors
08/28/14Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
08/28/14Pyrrolopyridines as kinase inhibitors
08/07/146-substituted phenoxychroman carboxylic acid derivatives
08/07/14Pyrrolopyridines as kinase inhibitors
08/07/14Novel hydrogen sulfate salt
07/10/14Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
05/29/14Akt protein kinase inhibitors
04/10/14Pyrrolopyridines as kinase inhibitors
04/03/14Mitotic kinesin inhibitors and methods of use thereof
03/20/14Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/06/14Serine/threonine kinase inhibitors
02/13/14Triazolopyridine compounds as pim kinase inhibitors
02/13/14Triazolopyridine compounds as pim kinase inhibitors
01/23/14N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
01/16/14Mitotic kinesin inhibtors and methods of use thereof
01/02/14Triazolopyridine compounds as pim kinase inhibitors
01/02/146-substituted phenoxychroman carboxylic acid derivatives
12/19/13Serine/threonine kinase inhibitors
09/26/13Serine/threonine kinase inhibitors
09/05/13Combination of checkpoint kinase i inhibitors and wee i kinase inhibitors
06/06/13Pyrimidyl cyclopentanes as akt protein kinase inhibitors
05/23/135,7-substituted-imidazo[1,2-c]pyrimidines as inhibitors of jak kinases
04/04/135h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
03/21/13Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/14/132-aminopyridine analogs as glucokinase activators
03/14/13Dihydrofuro pyrimidines as akt protein kinase inhibitors
02/21/13Pyrrolopyridines as kinase inhibitors
01/17/13Raf inhibitor compounds and methods of use thereof
Social Network Patent Pack
12/27/12Dihydrothieno pyrimidines as akt protein kinase inhibitors
11/01/12Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
11/01/12Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/18/12Combinations comprising heterocyclic inhibitors of mek and methods of use thereof
10/11/12Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cfms inhibitors
09/13/12Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/16/12Aminodiazepines as toll-like receptor modulators
08/09/124-substituted phenoxyphenylacetic acid derivatives
07/12/12Substituted pyrazolo[1,5-a]pyrimidine compounds as mtor inhibitors
06/28/128-substituted benzoazepines as toll-like receptor modulators
Patent Packs
06/21/12Raf inhibitor compounds and methods of use thereof
06/21/121h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase
06/21/12Raf inhibitor compounds and methods of use thereof
05/03/12Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
04/26/127-phenoxychroman carboxylic acid derivatives
12/29/11Process for preparing benzimidazole compounds
12/29/11Process for preparing benzimidazole compounds
11/24/11Heterocyclic inhibitors of mek and methods of use thereof
11/17/112-aminopyridine analogs as glucokinase activators
11/10/11Piperidine-containing compounds and use thereof
08/11/11Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
07/28/11Heterocyclic inhibitors of mek and methods of use thereof
07/21/11Heterocyclic inhibitors of mek and methods of use thereof
06/30/11Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
06/16/11Triazolopyridine compounds as pim kinase inhibitors
06/16/11Triazolopyridine compounds as pim kinase inhibitors
05/26/11Kinase inhibitors and methods of use thereof
05/19/11Substituted benzoazepines as toll-like receptor modulators
05/05/116-substituted phenoxychroman carboxylic acid derivatives
04/21/11Substituted benzoazepines as toll-like receptor modulators
03/24/11Pyrrolopyridines as kinase inhibitors
03/17/11Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/03/11Pyrimidyl cyclopentanes as akt protein kinase inhibitors
01/06/11Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
01/06/11N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
12/30/10Mitotic kinesin inhibitors and methods of use thereof
12/30/10Pyrazole urea derivatives used as kinase inhibitors
12/23/10Pyrrolopyridines as kinase inhibitors
11/18/10Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/04/10Pyrazolopyridines as kinase inhibitors
Patent Packs
10/21/10N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/10Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/14/10Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/10Method of treatment using checkpoint kinase 1 inhibitors
10/14/10N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/10N3 alkylated benzimidazole derivatives as mek inhibitors
09/16/10Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
08/26/10Methods of synthesis of benzazepine derivatives
08/12/10Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
07/08/104-substituted phenoxyphenylacetic acid derivatives
06/10/10Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
06/10/10Process for preparing benzimidazole compounds
04/22/10Method of treatment using inhibitors of mitosis
04/22/102-aminopyridine derivatives as glucokinase activators
03/11/10Heterocyclic inhibitors of mek and methods of use thereof
03/11/10Raf inhibitor compounds and methods of use thereof
03/04/10Glucokinase activators
02/18/10Mitotic kinesin inhibitors and methods of use thereof
02/04/10Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
12/03/09Novel peptide inhibitors of hepatitis c virus replication
Social Network Patent Pack
10/29/09Quinazoline analogs as receptor tyrosine kinase inhibitors
10/01/09Glucokinase activators
10/01/09Pharmaceutical composition 271
08/27/09Heterocyclic inhibitors of mek and methods of use thereof
08/20/09Heterocyclic inhibitors of mek and methods of use thereof
08/20/09Thiazoliums as transketolase inhibitors
07/02/09Novel macrocyclic inhibitors of hepatitis c virus replication
06/18/092-aminopyridine analogs as glucokinase activators
06/11/09Novel macrocyclic inhibitors of hepatitis c virus replication
06/11/09P38 inhibitors and methods of use thereof
06/04/09Heterocyclic inhibitors of mek and methods of use thereof
06/04/09P38 inhibitors and methods of use thereof
06/04/09Heterocyclic inhibitors of mek and methods of use thereof
05/28/09P38 inhibitors and methods of use thereof
05/21/09Heterocyclic inhibitors of mek and methods of use
02/19/09Quinazoline analogs as receptor tyrosine kinase inhibitors
02/19/09Compounds and methods of use







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Array Biopharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Array Biopharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';